Novavax Inc (NASDAQ:NVAX)
| 41.45 Delayed Data As of 4:00pm ET |  +1.11 / +2.75%Today’s Change | 34.88 Today|||52-Week Range 277.80 | -71.03% Year-to-Date |
Latest NVAX News | Press Releases
| 1 Robinhood Stock to Avoid Right Now 10:30am / MotleyFool.com - Paid Partner Content | 3 Companies Growing Revenue Fast Aug 10 / GuruFocus News - Paid Partner Content |
| Why Novavax Stock Was Plummeting This Week 7:45am / MotleyFool.com - Paid Partner Content | 1 Reason to Sell Novavax Stock, and 1 Reason to Buy Aug 10 / MotleyFool.com - Paid Partner Content |
| Novavax's Revenue Could Fall Even More -- and It's Actually Good News 5:52am / MotleyFool.com - Paid Partner Content | Bausch (BHC) Q2 Earnings & Sales Miss, View Cut, Stock Down Aug 10 / Zacks.com - Paid Partner Content |
| Is This Battered Growth Stock Still a Buy After Its Latest Stumble? Aug 11 / MotleyFool.com - Paid Partner Content | Stock Market News for Aug 10, 2022 Aug 10 / Zacks.com - Paid Partner Content |
| Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y Aug 10 / Zacks.com - Paid Partner Content | Nasdaq Bear Market: 3 Remarkable Growth Stocks That Can Double Your Money by 2026 Aug 10 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 40.34 |
| Today’s open | 40.91 |
| Day’s range | 40.54 - 43.04 |
| Volume | 139,407 |
| Average volume (3 months) | 6,903,160 |
| Market cap | $4.6B |
Data as of 4:00pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | -222.51% |
| Earnings growth (this year) | +203.61% |
| Earnings growth (next 5 years) | -1,485.02% |
| Revenue growth (last year) | +141.02% |
| P/E ratio | NM |
| Price/Sales | 9.29 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FATEFate Therapeutics In... | +1.17 | +3.58% |
| ---- | ||
| ARVNArvinas Inc | -0.11 | -0.20% |
| ---- |
Data as of 4:00pm ET, 08/12/2022
Financials
| Next reporting date | November 3, 2022 |
| EPS forecast (this quarter) | $4.10 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | -$1.7B |
| Net profit margin | -152.12% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
